https://www.thebodypro.com/author/barbara-jungwirth
Barbara Jungwirth

Barbara Jungwirth

Barbara Jungwirth is an experienced freelance journalist, writer, and translator who has been reporting on HIV for TheBody and TheBodyPro since 2002. Specializing in technical summaries of published and presented research on HIV and related topics, Barbara has been the primary author of TheBodyPro's "This Week in HIV Research" series since 2014.

Latest by Barbara Jungwirth

heart anatomical model
News

This Week in HIV Research: A Heart-y Exploration

Jan. 20, 2020: Protease inhibitors and heart attack risk; HIV status and pericardial adipose tissue volume; cardiovascular risk profiles on TDF vs. TAF; hemostatic profiles in older people living with HIV.

blue pills on blue background
News

This Week in HIV Research: PrEP Relief

Feb. 13, 2020: PrEP's psychosocial benefits; supplementing ADAP with Obamacare plans; lack of HIV and HCV testing for people who inject drugs; frailty is more common, but not more deadly, in HIV settings.

doctor getting ready to give patient vaccine
News Analysis

HIV Vaccine Trial Stopped Early, but Research Into Other Approaches Continues

HVTN 702 is but one of many vaccine trials underway, researchers note.

many one dollar bills
News

This Week in HIV Research: As Pill Burden Drops, Pill Cost Rises

Feb. 6, 2020: HIV medication costs outpace inflation; HIV's role in attenuating childhood vaccinations; the challenges of researching effects of medications during pregnancy; the need for localized HIV interventions in the U.S.

two elderly people sitting and looking at water
News

This Week in HIV Research: Our Attunement to Aging

Jan. 30, 2020: Polypharmacy vs. drug interaction risk among people living with HIV as they age; cost-effectiveness of ibalizumab; PrEP persistence on Medicaid vs. private health coverage.

close up of cannabis plant
News

This Week in HIV Research: More Answers—and Questions—on Cannabis Use

Jan. 23, 2020: Neurocognitive benefits of cannabis use; how unquantifiable HIV in CSF correlates to executive function; updated findings on efavirenz and microcephaly; cost-efficacy of a specialized HIV care coordination team.

woman's hand using phone
News

This Week in HIV Research: Just a Text Away

Jan. 16, 2020: Texting (and stigma support) vs. email for care retention; beyond-childhood health risks for HIV-exposed infants; HIV, cardiovascular risk, and cognitive impairment; direct-acting antiviral efficacy and prescription delays.

three human skeleton models doing "see no evil, hear no evil, speak no evil"
News

This Week in HIV Research: Bone Concerns Aren’t Just for Older Folks

Jan. 9, 2020: Bone loss after HIV treatment initiation; aging and antiretroviral dosage; more U=U evidence for women; viral suppression and executive function.

woman in headscarf receiving chemotherapy in yellow room
Research

This Week in HIV Research: A New Year, an Old Enemy

Jan. 2, 2020: Cancer treatment among people with HIV in the Obamacare era; chemotherapy, CD4 count, and mortality; cutting meds to cut costs; tailoring interventions on the microepidemic level.

hand reaching
News

This Week in HIV Research: Where Our Reach Falls Short

Dec. 19, 2019: Often-insufficient CD4 and viral load testing for women; factors affecting syphilis incidence among women with HIV; STI testing rates among people with HIV; the effect of benzodiazepines on neurocognition.